RT Journal Article
SR Electronic
T1 Endemic means change as SARS-CoV-2 evolves
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.09.28.23296264
DO 10.1101/2023.09.28.23296264
A1 Otto, Sarah P.
A1 MacPherson, Ailene
A1 Colijn, Caroline
YR 2023
UL http://medrxiv.org/content/early/2023/09/29/2023.09.28.23296264.abstract
AB COVID-19 has become endemic, with dynamics that reflect the waning of immunity and re-exposure, by contrast to the epidemic phase driven by exposure in immunologically naïve populations. Endemic does not, however, mean constant. Further evolution of SARS-CoV-2, as well as changes in behaviour and public health policy, continue to play a major role in the endemic load of disease and mortality. In this paper, we analyse evolutionary models to explore the impact that newly arising variants can have on the short-term and longer-term endemic load, characterizing how these impacts depend on the transmission and immunological properties of variants. We describe how evolutionary changes in the virus will increase the endemic load most for persistently immune-escape variants, by an intermediate amount for more transmissible variants, and least for transiently immune-escape variants. Balancing the tendency for evolution to favour variants that increase the endemic load, we explore the impact of vaccination strategies and non-pharmaceutical interventions (NPIs) that can counter these increases in the impact of disease. We end with some open questions about the future of COVID-19 as an endemic disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding was provided by the Natural Sciences and Engineering Research Council of Canada to SPO (RGPIN- 2022-03726), to AM (RGPIN-2022-03113), and to CC (CANMOD; RGPIN-2019-06624), by the Canada Research Chairs Program (SPO and AM) and the Canada 150 Research Chair Program (CC), and by the Canadian Institutes for Health Research (CIHR) operating grant to CoVaRR-Net.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript, as well as accompanying supplementary material (available online) http://www.zoology.ubc.ca/~otto/Research/Endemic